Nutex Health (NASDAQ:NUTX) Posts Quarterly Earnings Results, Beats Expectations By $0.17 EPS

Nutex Health (NASDAQ:NUTX) issued its quarterly earnings results on Thursday. The company reported $5.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.54 by $0.17, FiscalAI reports. The firm had revenue of $217.61 million for the quarter, compared to analyst estimates of $214.82 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.

Nutex Health Stock Performance

NUTX stock traded down $13.08 on Friday, reaching $180.56. The company’s stock had a trading volume of 167,920 shares, compared to its average volume of 167,060. Nutex Health has a 52 week low of $83.99 and a 52 week high of $226.16. The company has a market capitalization of $1.24 billion, a P/E ratio of 7.09 and a beta of 0.66. The firm has a fifty day moving average of $203.37 and a two-hundred day moving average of $151.24. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96.

Analyst Ratings Changes

A number of brokerages recently commented on NUTX. B. Riley Financial reissued a “buy” rating on shares of Nutex Health in a report on Friday, September 4th. Zacks Research downgraded shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Wall Street Zen lowered Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday, October 31st. Weiss Ratings upgraded Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. Finally, LADENBURG THALM/SH SH began coverage on Nutex Health in a research report on Monday, October 26th. They set a “buy” rating and a $336.00 price target on the stock. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $323.67.

Insider Transactions at Nutex Health

In related news, Director Scott Saunders sold 203 shares of the company’s stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the completion of the sale, the director owned 400 shares of the company’s stock, valued at $85,700. This represents a 33.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 44.68% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.